One Health Group
Health Care · Cybersecurity
$3.2Mtotal raised · 2 rounds on record
$2.6Mlatest round · Venture round · Aug 2023 · 3 yr ago
$1Mrevenue · 2023 · SEC Form D 0001972911-24-000001
1backers · Alamo Angels
Overview
One Health Group develops AI-powered medical technology innovations to advance animal and human health.
Funding and backers
Total raised
$3.2M
2 rounds on record
Latest round
$2.6M
Venture round · Aug 2023 · 3 yr ago
Team
11-50
employees, estimated range
Revenue
$1M
2023 · SEC Form D 0001972911-24-000001
Backers
1
Alamo Angels
The money's age
Long since its last round
39 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 5, 2023
Raised a round Venture round $2.6M · SEC Form D
Jul 17, 2023
Raised a round Venture round $660k · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2023 | $2.6M | — | SEC Form D |
| Venture round | Jul 2023 | $660k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | One Health Group, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Albert Di RienzoExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Who we are. 2026-06-23 : [BIO2026] Achira Works With NVIDIA to Advance Molecular World Models for Agentic Discovery.
ProtaBody specializes in revolutionary protein engineering and design solutions to advance biotech and medical research.
We develop AI-based products that make communications faster and more efficient. Textly.
Effortless charting for clinicians. Save 80% of your time with AI-powered medical scribing. Try OneChart.ai today!
About Us Work on What Matters At LUMABS BV, we are driven by a clear mission: to advance quantitative antibody detection.
Free Flow Medical – lung experts, working to advance pulmonary medicine. Introducing the FreeFlow® Coil System for severe Emphysema…
Financials
Est. Annual Revenue
$500k
2023
Total raised
$3.2M
Latest round
Venture - Series Unknown
Funding rounds
2
Revenue
0% YoY
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2022 | $500k | $1 | $1M |
| 2023 | $500k | $1 | $1M |
People
Albert Di Rienzo
Executive Officer, Director
Michael Stanfield
Director
Carl Eckstein
Director
Mark Wang
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Alamo AngelsVia a fund
41 portfolio companies: Merit Medical Systems, Robot Creative, Texas Research and Technology Foundation and 38 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cazenovia
United States
HQ
10-50 est. staff